These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor]. Wang Z. Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120 [Abstract] [Full Text] [Related]
3. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors. Miao T, Wang Z, Sang N, Xiong R, Cao S. Eur Urol; 1992 Aug; 21(2):98-102. PubMed ID: 1499623 [Abstract] [Full Text] [Related]
5. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. Pantazopoulos D, Ioakim-Liossi A, Karakitsos P, Aroni K, Kakoliris S, Kanavaros P, Kyrkou KA. Anticancer Res; 1997 Aug; 17(1B):781-6. PubMed ID: 9066620 [Abstract] [Full Text] [Related]
6. [Studies on nuclear DNA content in bladder cancers using flow cytometry]. Toyota K. Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374 [Abstract] [Full Text] [Related]
7. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis. Malmström PU. Scand J Urol Nephrol Suppl; 1988 Jan; 112():1-55. PubMed ID: 3068792 [Abstract] [Full Text] [Related]
8. [Quantitation of Ras p21 oncogene and DNA content of gastrointestinal smooth muscle tumors and prognostic significance]. Cai J, Jiang Y, Zhang Y. Zhonghua Wai Ke Za Zhi; 1995 Apr; 33(4):225-8. PubMed ID: 7587676 [Abstract] [Full Text] [Related]
9. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer. Malekzadeh K, Sobti RC, Nikbakht M, Shekari M, Hosseini SA, Tamandani DK, Singh SK. Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091 [Abstract] [Full Text] [Related]
11. Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer. Lee SE, Chow NH, Chi YC, Tzai TS, Yang WH, Lin SN. Anticancer Res; 1994 Jan; 14(3B):1317-24. PubMed ID: 7915094 [Abstract] [Full Text] [Related]
13. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. Garcia del Muro X, Condom E, Vigués F, Castellsagué X, Figueras A, Muñoz J, Solá J, Soler T, Capellà G, Germà JR. Cancer; 2004 May 01; 100(9):1859-67. PubMed ID: 15112266 [Abstract] [Full Text] [Related]
14. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group. Fradet Y, Tardif M, Bourget L, Robert J. Cancer Res; 1990 Jan 15; 50(2):432-7. PubMed ID: 2295082 [Abstract] [Full Text] [Related]
15. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer. Neulander E, Kaneti J, Chaimovitz C, Sion-Vardy N, Douvdevani A. J Urol; 1997 Apr 15; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914 [Abstract] [Full Text] [Related]
16. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study]. Xue J. Zhonghua Wai Ke Za Zhi; 1989 Nov 15; 27(11):650-3, 700. PubMed ID: 2632194 [Abstract] [Full Text] [Related]
18. Immunohistochemical study of the ras oncogene expression in human bladder endoscopy specimens. Agnantis NJ, Constantinidou A, Poulios C, Pintzas A, Kakkanas A, Spandidos DA. Eur J Surg Oncol; 1990 Apr 15; 16(2):153-60. PubMed ID: 2182341 [Abstract] [Full Text] [Related]